CHARING SURGERY
1 SURGERY CLOSE, CHARING, ASHFORD
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 13 | 13 | 100.0% | |
| HF 4 | 2011 | 14 | 17 | 82.4% | |
| HF 4 | 2012 | 14 | 14 | 100.0% | |
| HF 4 | 2013 | 15 | 16 | 93.8% | |
| HF004 | 2014 | 7 | 7 | 100.0% | |
| HF004 | 2015 | 20 | 20 | 100.0% | |
| HF004 | 2016 | 19 | 20 | 95.0% | |
| HF004 | 2017 | 26 | 26 | 100.0% | |
| HF004 | 2018 | 32 | 34 | 94.1% | |
| HF004 | 2019 | 25 | 26 | 96.2% | |
| HF004 | 2020 | 44 | 50 | 88.0% | |
| HF006 | 2021 | 45 | 46 | 97.8% | |
| HF006 | 2022 | 47 | 47 | 100.0% | |
| HF006 | 2023 | 55 | 56 | 98.2% |
